Delivery Order SPE2DB22D3011-SPE2DB24FP9WG
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CONTRAVE ER 8-90 MG Tablet 120S. The delivery order has a ceiling value of $11,177.29 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. The delivery order is issued under a larger...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, with a ceiling value of $31,106.84, is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CONTRAVE ER 8-90 MG TABLET 120S. The order has a completion date of March 7, 2024 and a potential value of $3,840.37. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp is an experienced...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,637.26 award is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, with a potential value of $4,278.69 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the primary...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The order has a ceiling value of $8,109.36 and an ultimate completion date of July 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award, valued at $19,115.24, is for the delivery of 4564104295 - CONTRAVE ER 8-90 MG TABLET 120S, a prescription pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00, to provide a...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to provide Contrave ER 8-90 mg tablet 120s. The award has a ceiling value of $1,250.40 and a period of performance through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has a potential value of $4,923.68 and a period of performance through March 8, 2024. This order is not set-aside and is part of a larger indefinite delivery contract (IDC) valued...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a for-profit pharmaceutical distribution company. The contract has a ceiling value of $9,800.91 and a period of performance through April 9, 2024. It is for the provision of 4,564,205,098 units of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. No set-aside designation was used. AmerisourceBergen Drug Corp...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9WGDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for CONTRAVE ER 8-90 MG TABLET 120S, a specialty pharmaceutical product, with a ceiling value of $39,972.07 and a period of performance through March 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.0k | 3/14/24 |